GENE ONLINE|News &
Opinion
Blog

Aimmune Therapeutics
M&A
Nestlé to Acquire Aimmune Therapeutics in a $2.6 Billion Merger Agreement
2020-09-01
Nestlé to Acquire Aimmune Therapeutics in a $2.6 Billion Merger Agreement
2020-08-31
Aimmune’s PALFORZIA™ Scores FDA Win, Becomes the First Ever Treatment For Peanut Allergy
2020-02-01
FDA’s Advisory Committee Recommends Palforzia’s approval for Peanut Allergy Treatment
2019-09-27
LATEST
Neuro, Pain, and Cancer Top the List at JPM 2025 Healthcare Conference
2025-01-17
ZYN Nicotine Pouches Receive FDA Marketing Authorization
2025-01-17
Virginia’s Insurance Marketplace Extends Open Enrollment Deadline: A Detailed Report
2025-01-16
2025 Starts with a Jolt: Layoffs Hit the Life Sciences Industry Ahead of JPM
2025-01-16
Eli Lilly Steals the Spotlight at JPM 2025 with $2.5 Billion Power Move Acquisition
2025-01-16
Pre-JPM 2025: The Quiet Deals You May Have Missed Before the Big Show
2025-01-16
JPM 2025’s Billion Dollar Deal – GSK Bids Big in GI Cancer
2025-01-15
EVENT
2025-02-05
Precision Medicine World Conference 2025
Santa Clara, California
2025-02-19
Healthcare Conference Taipei 2025
Taipei, Taiwan
2025-03-17
BIO-Europe Spring 2025
Milan, Italy
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
Scroll to Top